These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19618071)

  • 1. Association of the ML Flow serologic test to slit skin smear.
    Lyon S; Castorina da Silva R; Lyon AC; Grossi MA; Lyon SH; Azevedo Mde L; Bührer-Sékula S; Rocha MO
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():23-6. PubMed ID: 19618071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil.
    Lyon S; Lyon AC; Da Silva RC; Grossi MA; Lyon SH; Bührer-Sékula S; Rocha MO
    Lepr Rev; 2008 Jun; 79(2):162-70. PubMed ID: 18711938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ML Flow seropositivity in leprosy patients.
    Grossi MA; Leboeuf MA; Andrade AR; Bührer-Sékula S; Antunes CM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():39-44. PubMed ID: 19618074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy serology (ML Flow test) in borderline leprosy patients classified as paucibacillary by counting cutaneous lesions: an useful tool.
    Barreto JA; Nogueira ME; Diorio SM; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():45-7. PubMed ID: 19618075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of ML Flow test in leprosy classification.
    Grossi MA; Leboeuf MA; Andrade AR; Lyon S; Antunes CM; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():34-8. PubMed ID: 19618073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
    Lefford MJ; Hunegnaw M; Siwik E
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the agreement between clinical and laboratorial exams in the diagnosis of leprosy.
    Teixeira AC; Cruvinel DL; Roma FR; Luppino LF; Resende LH; Sousa Td; Bührer-Sékula S; Goulart IM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():48-55. PubMed ID: 19618076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.
    Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L
    Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between leprosy reactions after treatment and bacterial load evaluated using anti PGL-I serology and bacilloscopy.
    Brito Mde F; Ximenes RA; Gallo ME; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():67-72. PubMed ID: 19618079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leprosy serology using PGL-I: a systematic review.
    Moura RS; Calado KL; Oliveira ML; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():11-8. PubMed ID: 19618069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti M. leprae IgM antibody determination by ultramicroimmunoenzymatic (UMELISA HANSEN) for the diagnosis and monitoring leprosy.
    Torrella A; Solis RL; Perez E; Medina Y; Kerguelen C; Olaya P
    Rev Inst Med Trop Sao Paulo; 1998; 40(3):177-81. PubMed ID: 9830732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM anti-phenolic glycolipid-I antibody measurements from skin-smear sites: correlation with venous antibody levels and the bacterial index.
    Butlin CR; Soares D; Neupane KD; Failbus SS; Roche PW
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):465-8. PubMed ID: 9465156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the ML-Flow test as a tool in classifying and treating leprosy.
    Contin LA; Alves CJ; Fogagnolo L; Nassif PW; Barreto JA; Lauris JR; Nogueira ME
    An Bras Dermatol; 2011; 86(1):91-5. PubMed ID: 21437528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the reproducibility of two serological assays for detection of Mycobacterium leprae infection.
    Parkash O
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):46-8. PubMed ID: 11480319
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy.
    Schuring RP; Moet FJ; Pahan D; Richardus JH; Oskam L
    Lepr Rev; 2006 Dec; 77(4):343-55. PubMed ID: 17343221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.